TSE:L

Loblaw Companies Ltd (L.TO)

66.47
+1.70 (2.62%)
as of Jun 24, 2026, 5:09:45 pm Market Open.
323 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.

consensus icon
Consensus
Positive
valuation icon
Valuation
Overvalued
review icon
Similar
CST, CST
BUY
At a 52 week high A good stock in a recession
Showing 706 to 706 of 706 entries